Drug recall · April 24, 2019
Divalproex Sodium Extended-Release Tablets recall
Why: cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Divalproex Sodium Extended-Release Tablets, USP, 250 mg a) 100-count bottle (NDC 55111-0533-01), b) 500-count bottle (NDC 55111-0533-05), Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, - 500 090 INDIA
- Lots / codes
Lot #: a) C802629, Exp. 03/2020; C805680, Exp. 07/2020, C808821,Exp. 10/2020; b) C806561, Exp. 10/2020
- Quantity
- 33,958 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Product was distributed to major distributors and retailers who may have further distribute the product throughout the United States.
- Initiated
- April 11, 2019 · Voluntary: Firm initiated
- Classified
- April 15, 2019
- Reported
- April 24, 2019
- Ended
- June 25, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valproate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.